Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Cancer|August 24, 2017
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinomaMaeve A Lowery, Kenneth H Yu, David Paul Kelsen, et al.Cancer|August 28, 2019
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomesMaeve A Lowery, Laura W Goff, Bridget P Keenan, et al.Cancer|January 9, 2019
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomesWinston Wong, Maeve A Lowery, Michael F Berger, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2025
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trialMaeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary CancersMaeve A Lowery, Mikaela Bradley, Joanne F Chou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and RecommendationsZishuo I Hu, Jinru Shia, Zsofia K Stadler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.Cancer|October 7, 2015
Identification of germline genetic mutations in patients with pancreatic cancerErin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, et al.Pageof 7